Nouvelle déclaration d'incident
No de la demande: 2020-2333
Numéro de référence du titulaire d'homologation: 2019-US-034230
Nom du titulaire (nom légal complet, aucune abbréviation): The Hartz Mountain Corporation
Adresse: 400 Plaza Drive
Ville: Secaucus
État: New Jersey
Pays: USA
Code postal /Zip: 07094-3688
Incident chez un animal domestique
Pays: UNITED STATES
État: NEW YORK
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 2596-153
Nom du produit: Hartz UltraGuard Rid Flea and Tick Shampoo with Oatmeal for Dogs
Liquide
Oui
Inconnu
Site: Animal / Usage sur un animal domestique
Propriétaire de l'animal
Dog / Chien
Jack Russell Terrier
1
Femme
4
14
lbs
Cutanée
>15 min <=2 hrs / >15 min <=2 h
>30 min <=2 hrs / >30 min <=2 h
Système
Persisted until death
Non
Non
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
On 27-Dec-2019, a 4 year old, approximately 14 pound, intact, female, Jack Russell Terrier dog, in unknown condition, with no known concomitant medical condition, was administered 1 dose of Hartz UltraGuard Rid Flea and Tick Shampoo with Oatmeal for Dogs (Phenothrin) via the topical route by the animal owner. Within 32 minutes of product administration, the dog developed lethargy. Approximately 1 hour post administration, the dog died at home. No necropsy had been performed.
Mort
Assessment: The active ingredient in this product is present in low concentration and has a wide margin of safety in dogs. The owner indicated that similar products had been used on the dog in the past without adversity. Sudden death is not anticipated after use and other causes should be considered including but not limited to underlying cardiac disease and unknown trauma. The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.